具有BCL2依赖性的非典型ETP-ALL病例的细胞遗传学和分子特征:对Venetoclax使用的治疗影响
Francesco Gigliotti1, Carolina Brescia2,3, Salvatore Audia2
1Renato Dulbecco University Hospital, Catanzaro, Italy.
Molecular biology reports
|September 18, 2025
概括
本案例研究详细介绍了一名患有耐火性早期T细胞前体急性淋巴细胞白血病 (ETP-ALL) 的儿科患者,该患者对venetoclax反应良好. 该疗法向BCL2通路激活,对类似的高风险白血病病例显示有前途.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 早期T细胞前体急性淋巴细胞白血病 (ETP-ALL) 是一种罕见的,高风险的T-ALL亚型.
- ETP-ALL与预后不佳,诱导失败和频繁复发有关.
- 针对ETP-ALL的有效向疗法仍然有限.
研究的目的:
- 报告一例具有新型遗传变异的多重耐火儿科ETP-ALL病例.
- 为了研究驱动耐火ETP-ALL的分子机制.
- 在这种情况下,评估venetoclax的治疗潜力.
主要方法:
- 一个儿科ETP-ALL患者的病例报告.
- 综合分子分析,包括细胞遗传学和基因表达.
- 活体药物敏感性测定.
- 慈悲的使用 venetoclax的管理.
主要成果:
- 确定了新的细胞遗传变化:4q删除和t(16;18)(q24;q21).
- 揭示了渐进的BCL2通路激活和破坏的Th17免疫标记物.
- 证明了BCL2依赖性的增加.
- 威尼托克拉克斯治疗导致了血液的快速恢复和爆发的减少.
结论:
- 克隆进化和免疫失调有助于复发性ETP-ALL中BCL2成.
- 威尼托克拉克斯在耐火儿科ETP-ALL中显示出治疗潜力.
- 这一案例强调了在ETP-ALL中准BCL2的重要性.
更多相关视频
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K